ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $854.11 million. The enterprise value is $553.90 million.

Market Cap	854.11M
Enterprise Value	553.90M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

AVBP has 41.28 million shares outstanding. The number of shares has increased by 52.43% in one year.

Current Share Class	41.28M
Shares Outstanding	41.28M
Shares Change (YoY)	+52.43%
Shares Change (QoQ)	+19.73%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	61.02%
Float	23.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.77
P/TBV Ratio	2.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.90, with a Debt / Equity ratio of 0.00.

Current Ratio	14.90
Quick Ratio	13.95
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.84% and return on invested capital (ROIC) is -34.84%.

Return on Equity (ROE)	-51.84%
Return on Assets (ROA)	-32.78%
Return on Invested Capital (ROIC)	-34.84%
Return on Capital Employed (ROCE)	-53.25%
Revenue Per Employee	n/a
Profits Per Employee	-$2.90M
Employee Count	52
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-35.06%
50-Day Moving Average	19.09
200-Day Moving Average	20.73
Relative Strength Index (RSI)	59.60
Average Volume (20 Days)	352,096

Short Selling Information

The latest short interest is 6.93 million, so 16.78% of the outstanding shares have been sold short.

Short Interest	6.93M
Short Previous Month	7.06M
Short % of Shares Out	16.78%
Short % of Float	29.54%
Short Ratio (days to cover)	22.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-162.42M
Pretax Income	-150.98M
Net Income	-150.98M
EBITDA	n/a
EBIT	-162.42M
Earnings Per Share (EPS)	-$4.18

Balance Sheet

The company has $300.27 million in cash and $56,000 in debt, giving a net cash position of $300.21 million or $7.27 per share.

Cash & Cash Equivalents	300.27M
Total Debt	56,000
Net Cash	300.21M
Net Cash Per Share	$7.27
Equity (Book Value)	305.00M
Book Value Per Share	7.47
Working Capital	299.66M

Cash Flow

Operating Cash Flow	-146.08M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.43%
Shareholder Yield	-52.43%
Earnings Yield	-17.68%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $38.00, which is 83.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.00
Price Target Difference	83.66%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1